PATENT CLAIM ANALYSIS

Application Number: 16223571
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "423000"]

Abstract:
Effective treatments of pain and/or inflammation are provided. Through the administration of a porous biodegradable drug depot film, patch, strip or sponge being implantable within a nasal or sinus cavity and having pores sized to prevent the depot from functioning as a scaffold for tissue growth, one can reduce, prevent or treat pain and/or inflammation and prevent cells from infiltrating the drug depot and laying down scaffolding cells.

Claim (Index 9):
The method of  claim 2 , wherein the three drug pellets are configured to release between 0.001 \u03bcg/day and 35 \u03bcg/day of the clonidine after the administering, wherein each drug pellet of the three drug pellets comprises the pharmaceutically acceptable salt of clonidine, wherein each drug pellet of the three drug pellets comprises a length between 0.5 mm and 5 mm and a diameter between 0.01 mm and 2 mm, and wherein each drug pellet of the three drug pellets comprises an immediate release layer and a sustain release layer.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 98.0
- Lexical Diversity: 1.45098
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13891239', '13180685', '12424368', '13310240', '14730395']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7900099005038362
- 35 USC 102 Novelty (BERT): 0.5318899729528717
- Combined Prediction Score: 0.7641979077487397
- Mean Citation Score: 348.102386
- Max Citation Score: 363.42822
- Similarity Product: 270.9496769068694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test